Patient Reported Outcomes after Hypofractionated Radiotherapy and Long-term Androgen Deprivation for High-risk Prostate Cancer

被引:0
|
作者
Quon, H. C. [1 ]
Loblaw, D. A. [1 ]
Morton, G. [1 ]
Szumacher, E. [1 ]
Danjoux, C. [1 ]
Choo, R. [2 ]
Thomas, G. [1 ]
Kiss, A. [1 ]
Deabreu, A. [1 ]
Cheung, P. C. F. [1 ]
机构
[1] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[2] Mayo Clin, Rochester, MN USA
关键词
D O I
10.1016/j.ijrobp.2010.07.817
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S345 / S345
页数:1
相关论文
共 50 条
  • [1] Very high-risk prostate cancer: stratification by outcomes of radiotherapy and long-term androgen deprivation therapy
    Tomita, Natsuo
    Soga, Norihito
    Ogura, Yuji
    Kageyama, Takumi
    Kodaira, Takeshi
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (03) : 145 - 151
  • [2] Moderately Hypofractionated Radiotherapy and Androgen Deprivation Therapy for High-risk Localised Prostate Cancer: Predictors of Long-term Biochemical Control and Toxicity
    Maulik, S.
    Arunsingh, M.
    Arun, B.
    Prasath, S.
    Mallick, I
    [J]. CLINICAL ONCOLOGY, 2022, 34 (01) : E52 - E60
  • [3] High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term androgen deprivation therapy for very high-risk prostate cancer
    Kasahara, Takashi
    Ishizaki, Fumio
    Kazama, Akira
    Yuki, Eri
    Yamana, Kazutoshi
    Maruyama, Ryo
    Oshikane, Tomoya
    Kaidu, Motoki
    Aoyama, Hidefumi
    Bilim, Vladimir
    Nishiyama, Tsutomu
    Tomita, Yoshihiko
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (09) : 800 - 806
  • [4] Patient Reported Outcomes in High-Risk Prostate Cancer Patients with or without Testosterone Recovery after Androgen Deprivation Therapy
    Nabid, A.
    Carrier, N.
    Martin, A. G.
    Bahary, J. P.
    Vavassis, P.
    Vass, S. T., Jr.
    Bahoric, B.
    Archambault, R.
    Vincent, F.
    Bettahar, R.
    Souhami, L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S95 - S96
  • [5] Long-term outcomes for men with high-risk prostate cancer treated definitively with external-beam radiotherapy with or without androgen deprivation
    Elliott, Sean P.
    [J]. CANCER, 2013, 119 (18) : 3260 - 3261
  • [6] Hypofractionated radiotherapy and androgen deprivation in intermediate risk prostate cancer
    Bracci, S.
    Osti, M. F.
    Agolli, L.
    Bertaccini, L.
    De Sanctis, V.
    Valeriani, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S641 - S641
  • [7] Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer
    Yong Luo
    Mingchuan Li
    Hengzhi Qi
    Jiahui Zhao
    Yili Han
    Yunhua Lin
    Zhu Hou
    Yongguang Jiang
    [J]. World Journal of Surgical Oncology, 16
  • [8] Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer
    Luo, Yong
    Li, Mingchuan
    Qi, Hengzhi
    Zhao, Jiahui
    Han, Yili
    Lin, Yunhua
    Hou, Zhu
    Jiang, Yongguang
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
  • [9] Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes
    Ahmadi, Hamed
    Daneshmand, Siamak
    [J]. PATIENT-RELATED OUTCOME MEASURES, 2014, 5 : 63 - 70
  • [10] Radiotherapy with androgen deprivation in high-risk prostate cancer: What outcomes on a Caribbean population?
    Kamwa, A. D. Foahom
    Vian, E.
    Agoua, G.
    Senechal, C.
    Bentaleb, Y.
    Fofana, M.
    Manip-M'Ebobisse, N.
    Blanchet, P.
    [J]. PROGRES EN UROLOGIE, 2012, 22 (15): : 954 - 962